Amedeo Smart

Free Medical Literature Service



Bladder Cancer

  Free Subscription

Articles published in
Cancer Res
    April 2017
  1. VAN KAMPEN JGM, van Hooij O, Jansen CF, Smit FP, et al
    miRNA-520f Reverses Epithelial-to-Mesenchymal Transition by Targeting ADAM9 and TGFBR2.
    Cancer Res. 2017;77:2008-2017.
    >> Share

    March 2017
  2. NICHOLSON J, Jevons S, Groselj B, Ellermann S, et al
    E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer.
    Cancer Res. 2017 Mar 31. pii: canres.3232.2016.
    >> Share

    February 2017
  3. MIAO L, Liu Q, Lin CM, Luo C, et al
    Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.
    Cancer Res. 2017;77:719-731.
    >> Share

    January 2017
  4. OWCZAREK TB, Kobayashi T, Ramirez R, Rong L, et al
    ARF confers a context-dependent response to chemotherapy in muscle invasive bladder cancer.
    Cancer Res. 2017 Jan 12. pii: canres.2621.2016.
    >> Share

    August 2016

  5. Correction: ATF3 Suppresses Metastasis of Bladder Cancer by Regulating Gelsolin-Mediated Remodeling of the Actin Cytoskeleton.
    Cancer Res. 2016;76:4592.
    >> Share

    March 2016
  6. WANG M, Li Z, Chu H, Lv Q, et al
    Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3.
    Cancer Res. 2016.
    >> Share

    December 2015
  7. LI C, Du Y, Yang Z, He L, et al
    GALNT1-mediated glycosylation and activation of sonic hedgehog signaling maintains the self-renewal and tumor-initiating capacity of bladder cancer stem cells.
    Cancer Res. 2015 Dec 16. pii: canres.2309.2015.
    >> Share

    October 2015
  8. PALMBOS PL, Wang L, Yang H, Wang Y, et al
    ATDC/TRIM29 drives invasive bladder cancer formation through microRNA-mediated and epigenetic mechanisms.
    Cancer Res. 2015 Oct 15. pii: canres.0603.2015.
    >> Share

  9. REMY E, Rebouissou S, Chaouiya C, Zinovyev A, et al
    A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder Tumorigenesis.
    Cancer Res. 2015;75:4042-52.
    >> Share

    May 2015
  10. HE F, Melamed J, Tang MS, Huang C, et al
    Oncogenic HRAS Activates Epithelial-to-Mesenchymal Transition and Confers Stemness to p53-Deficient Urothelial Cells to Drive Muscle Invasion of Basal Subtype Carcinomas.
    Cancer Res. 2015;75:2017-28.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016